![]() |
|
|
Vol. 295, Issue 1, 67-73, October 2000
Laboratory of Neuropsychopharmacology, Department of Psychiatry and
Behavioral Sciences, Emory University School of Medicine, Atlanta,
Georgia
The acute and subchronic effects of a variety of doses of a
prototype typical (haloperidol) or one of several atypical
antipsychotic drugs (clozapine, olanzapine, risperidone, quetiapine, or
sertindole) on regional brain neurotensin (NT) tissue concentrations,
and NT receptor binding were examined. Acute administration of
haloperidol, clozapine, olanzapine, and risperidone dose-dependently
increased NT tissue concentrations in the nucleus accumbens.
Haloperidol, olanzapine, risperidone, and sertindole also increased NT
tissue concentrations in the caudate nucleus. NT tissue concentrations in the nucleus accumbens and caudate remained elevated after 14-day administration of haloperidol, olanzapine, sertindole, and risperidone. In contrast, at the doses studied, quetiapine decreased NT tissue concentrations in the nucleus accumbens; clozapine had no effect. Haloperidol significantly increased NT receptor binding in the substantia nigra after 14-day administration. All of the atypical antipsychotic drugs decreased NT receptor binding in the nucleus accumbens and in the substantia nigra. Although these studies do not
conclusively support the hypothesis that increased NT neurotransmission is involved in the clinically relevant effects of all antipsychotic drugs, the extant evidence clearly suggests that further study is
warranted. Inconsistencies in the data suggest that differential effects of antipsychotic drug administration on subpopulations of NT
neurons must be scrutinized further.
This article has been cited by other articles:
![]() |
C. Norman, S. Beckett, C. Spicer, D. Ashton, X. Langlois, and G. Bennett Effects of chronic infusion of neurotensin and a neurotensin NT1 selective analogue PD149163 on amphetamine-induced hyperlocomotion J Psychopharmacol, May 1, 2008; 22(3): 300 - 307. [Abstract] [PDF] |
||||
![]() |
F. St-Gelais, M. Legault, M.-J. Bourque, P.-P. Rompre, and L.-E. Trudeau Role of Calcium in Neurotensin-Evoked Enhancement in Firing in Mesencephalic Dopamine Neurons J. Neurosci., March 10, 2004; 24(10): 2566 - 2574. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Binder, B. Kinkead, M. J. Owens, and C. B. Nemeroff Neurotensin and Dopamine Interactions Pharmacol. Rev., December 1, 2001; 53(4): 453 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Binder, B. Kinkead, M. J. Owens, C. D. Kilts, and C. B. Nemeroff Enhanced Neurotensin Neurotransmission Is Involved in the Clinically Relevant Behavioral Effects of Antipsychotic Drugs: Evidence from Animal Models of Sensorimotor Gating J. Neurosci., January 15, 2001; 21(2): 601 - 608. [Abstract] [Full Text] [PDF] |
||||